157 related articles for article (PubMed ID: 20139035)
1. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model.
Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW
Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035
[TBL] [Abstract][Full Text] [Related]
2. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
[TBL] [Abstract][Full Text] [Related]
3. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
[TBL] [Abstract][Full Text] [Related]
5. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
[TBL] [Abstract][Full Text] [Related]
6. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy.
Hamilton RG; Marcotte GV; Saini SS
J Immunol Methods; 2005 Aug; 303(1-2):81-91. PubMed ID: 16045925
[TBL] [Abstract][Full Text] [Related]
7. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
[TBL] [Abstract][Full Text] [Related]
8. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
[TBL] [Abstract][Full Text] [Related]
9. Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab.
Zheng L; Li B; Qian W; Zhao L; Cao Z; Shi S; Gao J; Zhang D; Hou S; Dai J; Wang H; Guo Y
Biochem Biophys Res Commun; 2008 Oct; 375(4):619-22. PubMed ID: 18725193
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
[TBL] [Abstract][Full Text] [Related]
11. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
[TBL] [Abstract][Full Text] [Related]
12. Generation of canine-human Fc IgE chimeric antibodies for the determination of the canine IgE domain of interaction with Fc epsilon RI alpha.
Hunter MJ; Vratimos AP; Housden JE; Helm BA
Mol Immunol; 2008 Apr; 45(8):2262-8. PubMed ID: 18187193
[TBL] [Abstract][Full Text] [Related]
13. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
14. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
[TBL] [Abstract][Full Text] [Related]
15. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
Tam SW; Demissie S; Thomas D; Daëron M
Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay.
Dearman RJ; Skinner RA; Deakin N; Shaw D; Kimber I
Toxicology; 2005 Jan; 206(2):195-205. PubMed ID: 15588913
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
[TBL] [Abstract][Full Text] [Related]
19. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
D'Amato G
Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies specific to the alpha-subunit of the mast cell's Fc epsilon R block IgE binding and trigger histamine release.
Baniyash M; Alkalay I; Eshhar Z
J Immunol; 1987 May; 138(9):2999-3004. PubMed ID: 2437203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
